Business
GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies"
GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies".
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Hosts Cutting-Edge Cannabis Symposium \"Innovation in Medical Cannabis Therapies\"\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Hosts Cutting-Edge Cannabis Symposium \"Innovation in Medical Cannabis Therapies\"\nPR Newswire\nLAS VEGAS, Sept. 20, 2018\n\n\n\nNationally recognized researchers from the Medical Cannabis World will discuss the benefits of medical cannabis\n LAS VEGAS, Sept. 20, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB:GBLX)  has mobilized cannabis industry thought leaders to discuss both the immense potential for cannabis-based therapies and the challenges of delivering on their medical promise under state regulated programs at their fourth annual \"Innovation in Medical Cannabis Therapies\" symposium on November 9th at the \"Keep Memory Alive\" Event Center at the Cleveland Clinic's Lou Ruvo Center for Brain Health in Las Vegas, NV.\n\nThis event has attracted innovative leaders in cannabis biotech, nanotech, metabolomics, cultivation and extraction tech.  GB Sciences is pleased to announce this will include representatives from US and international research universities, cannabis industry leaders, clinical research organizations, and cannabis tech companies. Topics will focus on the changing paradigm of the industry stressing the medical uses of cannabis as they become more established and rigorously applied.\n\"This event is dedicated to moving cannabis from alternative to mainstream medicine, and we are excited to welcome such a distinguished panel of speakers and guests,\" said Dr. Andrea Small-Howard, Chief Science Officer at GB Sciences. \"Our symposium is an open discussion and a place for innovators to connect and break down the technical and societal barriers to cannabis as medicine.\"\nFor event registration, visit www.GBSciences.com or contact Liz Bianco, Director of PR, at [email protected].\nAbout GB Sciences, Inc.\nGB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development....